ClearBridge Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-200
Closed -$23K 834
2020
Q2
$23K Hold
200
﹤0.01% 835
2020
Q1
$16K Hold
200
﹤0.01% 907
2019
Q4
$21K Hold
200
﹤0.01% 952
2019
Q3
$21K Hold
200
﹤0.01% 934
2019
Q2
$20K Hold
200
﹤0.01% 945
2019
Q1
$18K Hold
200
﹤0.01% 956
2018
Q4
$17K Hold
200
﹤0.01% 983
2018
Q3
$22K Hold
200
﹤0.01% 1006
2018
Q2
$22K Hold
200
﹤0.01% 970
2018
Q1
$20K Hold
200
﹤0.01% 976
2017
Q4
$20K Hold
200
﹤0.01% 996
2017
Q3
$19K Hold
200
﹤0.01% 1045
2017
Q2
$22K Hold
200
﹤0.01% 1027
2017
Q1
$20K Hold
200
﹤0.01% 1004
2016
Q4
$18K Hold
200
﹤0.01% 986
2016
Q3
$17K Hold
200
﹤0.01% 947
2016
Q2
$16K Hold
200
﹤0.01% 953
2016
Q1
$14K Hold
200
﹤0.01% 961
2015
Q4
$14K Hold
200
﹤0.01% 1004
2015
Q3
$12K Hold
200
﹤0.01% 1062
2015
Q2
$15K Hold
200
﹤0.01% 1047
2015
Q1
$15K Hold
200
﹤0.01% 1081
2014
Q4
$13K Sell
200
-600
-75% -$37.9K ﹤0.01% 1094
2014
Q3
$49K Buy
800
+600
+300% +$37K ﹤0.01% 965
2014
Q2
$12K Hold
200
﹤0.01% 1104
2014
Q1
$12K Hold
200
﹤0.01% 1063
2013
Q4
$11K Hold
200
﹤0.01% 1042
2013
Q3
$12K Hold
200
﹤0.01% 1011
2013
Q2
$13K Buy
+200
New +$11.9K ﹤0.01% 998

Other funds holding DGX

ClearBridge Investments's DGX Position: Q3 2020 in Review

ClearBridge Investments sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 200 shares — an estimated $23K sold.

ClearBridge Investments first reported a position in DGX in Q2 2013 and held it in 29 quarters. The position peaked at $49K in Q3 2014. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • ClearBridge Investments reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • ClearBridge Investments sold 200 Quest Diagnostics shares in Q3 2020, an estimated $23K.
  • ClearBridge Investments first reported a position in Quest Diagnostics in Q2 2013 and held it in 29 quarters.
  • ClearBridge Investments's Quest Diagnostics position peaked at $49K in Q3 2014.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.